Patents
May 21, 2020
USPTO LAUNCHES PRIORITIZED PROGRAM FOR COVID-19 RELATED INVENTIONS By: Katie Rubino On May 8, 2020, the United States Patent and Trademark Office (USPTO) announced the new […]
April 16, 2020
COVID-19: HYDROXYCHLOROQUINE- FRIEND OR FOE? By: Katie Rubino Around the world, there are presently 1,696,588 confirmed cases of COVID-19 in 213 countries and territories.[i] Further, some […]
March 26, 2020
CORONAVIRUS CATASTROPHE: THE VALUE OF INTELLECTUAL PROPERTY DURING AN ECONOMIC DOWNTURN By: Katie Rubino As the number of cases of the novel coronavirus around the world […]
March 19, 2020
COVID-19 EPIDEMIC: CAN THE COVID-19 VIRUS BE PATENTED? By: Katie Rubino Just last week, the outbreak of a novel coronavirus that originated in China, has been […]
January 18, 2019
Final Decision Reached in Initial Insulin IPR Proceeding By: Katie Rubino On December 12th, 2018 the U.S. Patent and Trademark Appeal Board (PTAB) […]
November 7, 2018
Are auditability and transparency exclusive to open-source software? Our expert panel discusses blockchain patents and the “Silcone Valley mindset" at our recent MIT Enterprise Forum event.
November 5, 2018
Court Case Review: University of California v. Broad Institute, Inc. #2017-1907 by Patent Attorney Katie Rubino. Case involves CRISPR-Cas9 patents held by Harvard and MIT.
October 26, 2018
Tom Serres is a massively successful startup entrepreneur, and our client. He dispels the myth that open-source and proprietary software are at odds with each other, he sees them as two sides of the same coin.
October 16, 2018
Sam Abassi owns a firm specializing in research, development, and implementation of software support to meet specific needs, mostly utilizing open-source solutions. He offers his perspective on some of the dangers and challenges with finding the right software solutions.